Characterization of the 5n5 kb promoter of human thromboxane synthase (TS) gene revealed a proximal positive regulatory sequence (PPRS, k90 to k25 bp) and several distal repressive elements. The maximal promoter activity was found to reside within the first 285 bp, " 75 % of which was contributed by the PPRS. The sequence between k365 and k665 bp exerted a strong repressive effect (" 55 %) on reporter gene expression independent of orientation and position, consistent with properties expected for a silencer. The sequence upstream of k665 bp to k5n5 kb contains mainly repressive elements which further reduce the promoter activity by 30 %. The 65 bp PPRS worked in an orientation-independent, but position-dependent, manner and could be further divided into two independent elements, PPRS " (k90 to k50 bp) and PPRS # (k50 to k25 bp). While similar nuclear factor(s) from different cell types interact with PPRS # , those interacting with PPRS " exhibit cell specificity. Internal sequence deletion and oligonucleotide competition es-
INTRODUCTION
Thromboxane synthase (TS) is a bifunctional, microsomal enzyme catalysing the synthesis of both thromboxane A # (TxA # ) and 12-hydroxyheptadecatrienoic acid (HHT) [1] . While the importance of TxA # , a vasoconstrictor and inducer of platelet aggregation, in haemostasis has long been recognized, the physiological role of HHT remains poorly defined. Clinically, a deficiency of platelet TS [2, 3] or mutations in the TxA # receptor gene [4] were shown to result in bleeding disorders, while an elevated level of TxA # has been postulated to play a crucial role in cardiovascular and renal diseases [5, 6] . Recent studies suggest that TS may also play an important role in the immune system. Supports for this notion are the findings that significant amounts of the TS transcript are expressed in spleen, thymus and myeloid cells [7] [8] [9] [10] , and that TxA # causes apoptotic DNA fragmentation of immature thymocytes via the TxA # receptor [11] . It is believed that TS activity in i o needs to be delicately controlled in order to maintain haemostasis as well as other TxA # -associated functions. Although the detailed molecular mechanisms remain largely unknown, studies in the past suggested that TS is subject to multiple-level regulation in i o. One of the better studied aspects of TS regulation is ' suicide inactivation ', in which TS loses its activity during catalysis as a result of covalent modification by its substrate prostaglandin endoperoxide H # (PGH # ) [12, 13] . This catalytic inactivation presumably serves as a safeguard mechanism to prevent overproduction of the potent autacoid. A second control mechanism at work might be the Abbreviations used : β-gal, β-galactosidase ; HHT, 12-hydroxyheptadecatrienoic acid ; luc, luciferase ; PGH 2 , prostaglandin endoperoxide H 2 ; PPRS, proximal positive regulatory sequence ; RLU, relative light units ; RT-PCR, reverse-transcription PCR ; PMA, phorbol 12-myristate 13-acetate ; TS, thromboxane synthase ; TxA 2 , thromboxane A 2 ; DTT, dithiothreitol ; GAPDH, glyceraldehyde-3-phosphate dehydrogenase ; SV40, simian virus 40 ; X-gal, 5-bromo-4-chloroindol-3-yl β-D-galactopyranoside.
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tablished that a binding sequence for NF-E2 in PPRS " (k60 tgctgattcat k50) was important for enhancing TS promoter activity in HL-60 cells. The presence of NF-E2 mRNA in HL-60 cells was demonstrated by reverse-transcription PCR amplification of the cDNA and Northern blot analysis. A 9-fold transactivation of luciferase (luc) reporter gene expression had been detected when NF-E2 cDNA was co-expressed with a TS promoter\luc construct. Despite the fact that NF-E2 and the ciselements could alter the efficiency of TS transcription, they were not sufficient for restricting cell-specific TS expression. Analysis of the methylation status at the TS promoter in several human cell lines reveals cell-specific patterns of methylation that might correlate with TS expression. Taken together, these results suggest that the expression of human TS gene is modulated by multiple factors including cis-elements, trans-activator(s), and possibly genomic methylation.
recently described ' alternative splicing ' of the TS transcript. A truncated TS mRNA, lacking the entire 12th exon encoding the haem-binding domain of the enzyme, has been reported in several human cell lines [14] . The encoded protein of this truncated transcript, however, exhibits no enzymic activity for the formation of either TxA # or HHT [14, 15] . Although both of these regulatory events operate at different levels, they could be regarded as post-transcriptional. To date, little is known about the mechanism(s) or factor(s) controlling TS gene transcription. We have recently reported the genomic structure and CA repeat polymorphism associated with the 150 kb human TS gene [16] . Our studies also indicated that transcription of human TS gene is initiated from multiple start sites and mainly TATAindependent [16, 17] . In this report, we describe the characterization of cis-regulatory elements within the 5n5 kb human TS gene promoter and provide evidence suggesting that TS gene expression is transactivated by NF-E2 and potentially modulated by cell-specific methylation.
MATERIALS AND METHODS

Plasmid constructions
The phTS5500\luc reporter vector containing the 5n5 kb (k5500 to j30 bp, relative to the major transcription start site [17] ) human TS gene promoter was constructed by cloning the promoter fragment into the HindIII site of the promoterless pGL-Basic luciferase (luc) vector (Promega, Madison, WI,
Figure 1 Luc gene expression in HL-60 cells controlled by various lengths of human TS gene promoter
The restriction sites and the relative positions of some used for expression vector construction are indicated schematically at the top. An arrow indicates the major transcription start sites [16, 17] . Transfection of HL-60 cells and normalization for transfection efficiency were carried out as described in the Materials and methods section. All promoter fragments used contain the same 3h end which is 30 bp downstream from the 5h-most nucleotide of the major transcription start sites [17] . The number next to each fragment indicates the length (bp) of the promoter. Triplicate plates of cells were transfected with each construct in each experiment. The data represent meanspS.D. (n l 4) of the relative luc activities, as compared with that obtained with the 285 bp promoter which was taken as 100 %. SV2, SV40 early promoter/enhancer ; SV0, promoterless.
U.S.A.). 5h-Deletion mutants containing the promoter from k4500 to k665 bp were obtained by double digestion of the phTS5500\luc construct with SmaI (a unique site in the multiple cloning sites) and an appropriate restriction enzyme which cut the promoter, as shown in Figure 1 . The ends were filled-in by Klenow DNA polymerase and re-ligated. Other mutants containing the promoter from k365 to k5 bp were obtained by unidirectional deletion of the promoter, using exonuclease III\S1 nuclease (Promega), or by PCR amplification of the desired fragments. The end sequences of these constructs were verified by dideoxy sequencing analysis [18] . Internal deletion of the promoter was achieved by joining the upstream and downstream fragments, each amplified by a pair of synthetic primers. For the ease of cloning, the primers were designed so that a KpnI site was generated at the junction of the amplified fragments.
Cell culture and transfections
All media were supplemented with 10 % (v\v) fetal-calf serum, 50 µg\ml streptomycin and 50 I.U.\ml penicillin (Gibco BRL). Cells were maintained at 37 mC under 95 % humidity and 5 % CO # . All the cell lines used were purchased from the American Type Culture Collection (A.T.C.C.). HL-60 (human promyelocytic leukaemia), K562 and HEL (both human erythroid leukaemia), and IC-21 (murine macrophage) cells were cultured in RPMI 1640 medium, PLC\PRF\5 (human hepatoma) and CHO (Chinese hamster ovary) cells in Dulbecco's modified Eagle's medium (DMEM), and GH $ (rat pituitary) cells in Minimum Essential Medium (MEM ; Biofluids, Inc., MD, U.S.A.). Plasmid DNA for transfection was prepared using the Maxi plasmid kit (Qiagen Inc., CA, U.S.A.). Two plasmids, pCMV-β-gal (Clontech) and pRSV-SEAP (an expression vector producing the secretory form of alkaline phosphatase, Tropix, Inc., Bedford, MA, U.S.A.), were used as control vectors for transfection efficiency. HL-60 and K562 cells were transfected by electroporation as previously described [17] . Briefly, 10( cells were electroporated in 1 ml of buffer containing 20 µg of a TS\luc construct, 5 µg of pCMV-β-gal and 5 µg of pRSV-SEAP using a Bio-Rad Gene Pulser set at 960 µF and 300 V. PLC\PRF\5, CHO and GH $ cells, were transfected using Lipofectamine (Gibco BRL) as the DNA carrier according to the manufacturer's protocols.
Alkaline phosphatase, luc and β-galactosidase ( β-gal) activity assays
Alkaline phosphatase activity was measured 24 h after transfection using the protocols and buffers provided in the PhosphaLight reporter gene assay kit (Tropix, Inc.). The culture medium was diluted with an equal volume of a dilution buffer and incubated at 65 mC for 30 min before the addition of 100 µl of assay buffer. After 5 min at room temperature, a reaction buffer was added and the samples were incubated for an additional 20 min at room temperature. Chemiluminescence was determined in a luminometer (Turner Designs Model 20E, Sunnyvale, CA, U.S.A.). Luc and β-gal activities were determined by chemiluminescence and spectrophotometry, respectively, using a commercial kit (Promega). Cell extracts were prepared in 400 µl of the lysis buffer. For luc assay, 20 µl of the extract were mixed with 100 µl of the luc assay reagent (470 µM luciferin, 270 µM coenzyme A and 530 µM ATP) and chemiluminescence was determined. To determine β-gal activity, cell extracts were incubated with an equal volume of the double-strength assay buffer (0n67 mg of O-nitrophenyl-β--galactopyranoside\ml) at 37 mC for 1 h or until the yellow colour developed. The absorbance at 415 nm was determined using a microplate reader (Bio-Rad). Luc activity was normalized with either the β-gal or alkaline phosphatase activity and expressed as relative light units (RLU). When luc activity was compared between two cell types, the transfection efficiency was directly determined from the percentage of cells stained blue with 5-bromo-4-chloroindol-3-yl β--galactopyranoside (X-gal) [19] .
Preparation of nuclear extracts
Nuclear extracts from various cell types were prepared according to the published methods [20, 21] with minor modifications. Cells [(2-3)i10)] were washed twice with PBS. The cell pellet (" 0n3 g) was resuspended in 2 vol. of buffer A [10 mM Hepes, pH 7n9, 10 mM KCl, 0n1 mM EDTA, 0n1 mM EGTA, 5 mM MgCl # , 0n75 mM spermidine, 0n15 mM spermine, 1 mM dithiothreitol (DTT), 1 mM PMSF, 1000 k-units of aprotinin per ml and 10 µM leupeptin]. After incubation for at least 15 min on ice, cells were disrupted in a Dounce homogenizer (20 strokes, pestle A) and 100 µl of a sucrose solution (75 % w\v in 5 mM MgCl # ) was added to the homogenate. The sample was quickly spun at full speed in an Eppendorff centrifuge for 1 min at 4 mC. The pelleted nuclei were resuspended in 1 ml of buffer B [6n8 % sucrose (w\v) in buffer A] and centrifuged under the same conditions. The nuclear pellet was then resuspended in 1 ml of extraction buffer [10 mM Tris\HCl, pH 8n5, 1n5 mM EDTA, 10 mM DTT, 10 % (v\v) glycerol, 0n8 M KCl, 1 mM PMSF, 1000 k-units of aprotinin per ml, and 10 µM leupeptin] and centrifuged at 130 000 g for 30 min. Protein concentration was determined by the dye-binding method using the Bio-Rad protein assay kit. The extracts were stored at k80 mC until use.
Electrophoretic mobility shift assays
Oligonucleotide probes were end-labelled using [γ-$#P]ATP and T4 polynucleotide kinase and purified twice through Bio-Gel P2 (Bio-Rad) spin columns. Binding reactions were carried out for 20 min at room temperature in a buffer containing 10 mM Hepes (pH 7n6), 50 mM KCl, 0n1 mM EDTA, 5 mM MgCl # , 5 mM DTT, 10 % (v\v) glycerol, 1 mg\ml BSA, 2 µg of poly(dI:dC):poly(dI:dC) (Pharmacia), 10 µg of nuclear extracts, and 2i10% c.p.m. of the probe in a final volume of 20 µl. Samples were electrophoresed in 5 % polyacrylamide gels (60 : 1 acrylamide\bisacrylamide ratio) at 15 V\cm. Gels were dried and exposed to XAR-5 films with one intensifying screen at k80 mC. For competition studies, the labelled probe was mixed with various amounts of an unlabelled competitor oligonucleotide prior to the addition of nuclear extracts. DNA-protein complexes were resolved as described above. The sequences of the oligonucleotides used are listed below with the recognition sites underlined. P1, 5h-tattgacagtgcagtcatcaaggaataaagttgctgattcattccttt-3h ; P2, 5h-attcattcctttacactgaaaccctttgttg-3h ; AP-1, 5h-cgcttgatgactcagccggaa-3h ; mutant AP-1, 5h-cgcttgatgacttggccggaa-3h ; NF-E2, 5h-tggggaacctgtgctgagtcactggag-3h ; and mutant NF-E2, 5h-tggggaacctgtgctaggtcactggag-3h.
Reverse-transcription PCR (RT-PCR) amplification of NF-E2 cDNA and Northern blot analysis of NF-E2 mRNA
Total RNA was isolated according to the acid\ guanidinium\thiocyanate procedure of Chomczynski and Sacchi [22] . RNA (5 µg) was reverse-transcribed in a reaction buffer (20 µl) containing 2n5 µM oligo(dT) "' , 50 mM Tris\HCl (pH 8n3), 75 mM KCl, 3 mM MgCl # , 1 mM of each of the dNTPs, 10 units of RNase inhibitor and 200 units of Moloney murine leukaemia virus reverse transcriptase (Gibco BRL) at 42 mC for 1 h. The synthesized first-strand cDNA (4 µl) was then used as the template for PCR amplification of NF-E2 cDNA. The sequences of the forward (5h-tgactccaccacaggtttct-3h) and reverse (5h-cttctggtctagagaactca-3h) primers correspond to k70 to k51 and j1211 to j1230, respectively, of the reported sequence of human NF-E2 cDNA [23] . The amplification was carried out in a final volume of 20 µl containing 200 µM dNTPs, 50 mM KCl, 10 mM Tris\HCl (pH 9n0), 1 % (v\v) Triton X-100, 1n5 mM MgCl # and 1n25 units Taq DNA polymerase under the following conditions : melting at 94 mC for 45 s, annealing at 55 mC for 30 s, and extension at 72 mC for 45 s for 30 cycles, followed by a final extension at 72 mC for 10 min. Amplified products were resolved in a 1n2 % agarose gel. As an internal control, a " 300 bp product of the human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA [24] was similarly amplified using two specific primers, 5h-cgtcttcaccaccatggaga-3h (360-379) and 5h-cggccatcacgccacagttt-3h (640-659). To detect NF-E2 mRNA, total RNA (15 µg) was fractionated by electrophoresis in a 1 % agarose gel containing 3n3 % formaldehyde and transferred on to a nylon membrane (Hybond, Amersham). The blot was subjected to Northern blot analysis as previously described [8] , using NF-E2 cDNA as the probe.
Transactivation NF-E2 cDNA was subcloned in both orientations into the eukaryotic expression vector pcDNA3 (Invitrogen) to produce pCMV\NF-E2(j) and pCMV\NF-E2(k), which contain NF-E2 cDNA in the correct and reverse orientation, respectively. Aliquots (15 µg each) of the resulting constructs were used to transfect CHO cells in the presence of the same amount of a luc reporter construct controlled by the TS, simian virus 40 (SV40) or BCKD:E2 [the 5h-flanking sequence (k290 to j8 bp) of murine branched-chain α-keto dehydrogenase E2 subunit gene, provided by Dr. Jeffrey Chinsky, University of Maryland School of Medicine] promoter. The latter two promoters contain no NF-E2-binding site and were used as negative controls. The pCMV-β-gal construct (5 µg) was included in all transfections for normalizing transfection efficiency.
Genomic Southern blot for methylation analyses
Genomic DNA was isolated from HL-60, K562, or PLC\PRF\5 cells using the Puregene DNA isolation kit (Gentra Systems, Inc., Research Triangle Park, NC, U.S.A.). The DNA (10 µg) was first digested with HindIII or NcoI enzyme followed by MspI or HpaII restriction digestion. The digested DNA was electrophoresed in a 1 % agarose gel, transferred on to a nylon membrane (Hybond-N, Amersham), and subjected to Southern blot analysis using an 800 bp PstI fragment of the TS promoter as the probe (see Figure 9A) . Hybridization was performed at 65 mC in a solution containing 4iSSC, 50 mM NaH # PO % (pH 7n0), 5iDenhardt's solution, 100 mg\ml of heat-denatured salmon sperm DNA, 10 % (w\v) dextran sulphate and the heatdenatured probe (1i10' c.p.m.\ml) for 20 h (1iSSC : 0.15 M NaCl\0n015 M sodium citrate ; 1iDenhardt's solution : 0.02 % Ficoll 400\0.02 % polyvinylpyrrolidone\0.002 % BSA). The blots were washed for 30 min at 65 mC in 0n5iSSC containing 0n1 % (w\v) SDS and exposed to XAR-5 films with one intensifying screen at k80 mC. 
RESULTS
Identification of cis-elements within the 5n5 kb TS promoter
To reveal the cis-regulatory elements, a 5n5 kb human TS promoter was deleted from the 5h-end to generate a series of shorter promoters and their ability to direct expression of the luc reporter gene was analysed in the TS-expressing HL-60 cells. As shown in Figure 1 , the highest reporter activity was obtained with the 285 bp promoter, which was more than 3-fold higher in promoter strength than the control SV40 promoter\enhancer. A significant decrease in the reporter activity was observed as the length of the promoter was increased beyond 285 bp. The major repressive effect (55 %) was exerted by the sequence between k365 and k665 bp. An additional 30 % decrease in the reporter activity was seen as the length of the promoter was increased from 755 bp to 5n5 kb, suggesting the presence of multiple repressive elements. Deletion of the promoter from 285 bp to 90 bp reduced the promoter strength by " 20-25 %. Further deletion of the promoter to 50 or 24 bp resulted in 2n5-or 10-fold, respectively, decreases in reporter activity, suggesting that the major positive regulatory sequence is located between k90 to k24 bp. No significant reporter activity was detectable when the cells were transfected with the shortest (5 bp) promoter.
The sequence between k665 and k365 bp functions as a silencer, while the proximal positive regulatory sequence (PPRS) located between k90 and k25 bp is enhancer-like To determine the orientation and position dependence of the major negative and positive regulatory sequences, each was cloned in different orientations and positions within the reporter
Figure 3 Protein-DNA interactions between PPRS and HL-60 nuclear extracts
Double-stranded oligonucleotide probes P1 (k90 to k43 bp) and P2 (k54 to k24 bp) were end-labelled with T4 polynucleotide kinase and [γ-32 P]ATP and incubated with nuclear extracts prepared from HL-60 cells in the absence and presence of the unlabelled probes (A and C) or poly(dI:dC) (B and D) as competitors. Binding reactions and competition were carried out as described in the Materials and methods section. Samples were subjected to 5 % nondenaturing polyacrylamide gel electrophoresis. Abbreviation : N.E., nuclear extract.
vector and used to transfect HL-60 cells. As shown in Figure 2 , the major repressive sequence (k665 to k365 bp) functioned as a silencer, as it repressed the reporter expression independent of orientation and position (Figure 2A ). It also worked on the heterologous SV40 promoter, suggesting that its activity is independent of the presence of the proximal positive regulatory sequence (PPRS). The PPRS stimulated reporter gene expression in both correct and reverse orientations, although the stimulatory effect was more prominent in the correct orientation. No significant stimulation was observed when the fragment was cloned 3h to the reporter gene ( Figure 2B ).
Different protein factors interact with distinctive regions of the PPRS
The deletion analysis (Figure 1 ) indicated that the PPRS could be
Figure 4 Distinctive transcription factor(s) interacting with P1 and P2
Electrophoretic mobility shift assays were performed using the same amount (10 µg) of nuclear extracts prepared from various cell types as indicated. Probe labelling and DNA-protein complex analysis were as described in the legend to Figure 3. divided into two regions, PPRS " (k90 to k50 bp) and PPRS # (k50 to k24 bp). To identify protein factors interacting with the PPRS, band-shift assays were carried out using two probes (k90 to k43 bp, and k54 to k24 bp ; referred as P1 and P2, respectively) and the HL-60 nuclear extracts. The two probes were designed to overlap each other to assure that proteins binding at the junction (k50) of PPRS "
and PPRS # could be detected. As shown in Figure 3 , specific protein-DNA interactions were observed with both probes, which were sensitive to competition by the unlabelled probe ( Figures 3A and 3C ), but not by the poly(dI:dC) competitor ( Figures 3B and 3D ), suggesting that the interactions were specific. We have confirmed that P1 and P2 could not cross-compete each other for their respective complex (results not shown), suggesting that different proteins interacted with these probes. To see if there were quantitative differences in the amounts of the PPRS-interacting proteins in different cell types, band-shift assays were carried out using nuclear extracts from six cell lines. As shown in Figure 4 , while the amounts of protein factor(s) interacting with the P2 probe were similar in all the cell lines, only nuclear extracts from HL-60, HEL and K562 cells interacted significantly with the P1 probe, suggesting that P1-binding protein(s) may be cell-specific.
Figure 5 Effects of internal deletion of PPRS 1 , PPRS 2 , AP-1-binding site, and the sequence k12 to k4 on the strength of TS promoter
The construction of TS promoter/luc gene vectors with internal deletions has been described in the Materials and methods section. The plasmids were used to transfect HL-60 cells as described in the legend to Figure 1 . Luc activities were expressed relative to that obtained with the 365 bp promoter which was taken as 100 %. The results are the meanspS.D. of two experiments using triplicate samples for each construct.
Figure 6 Competition of protein/P1 complex by the wild-type or mutant NF-E2 oligonucleotide probe
Left panel : protein-DNA complex formation between NF-E2 probe and HL-60 nuclear extracts. Middle and right panels : competition of complex formed between HL-60 nuclear extracts and P1 probe by the unlabelled wild-type (middle panel) or mutant (mt, right panel) NF-E2 probe. Probes (10 4 c.p.m.) were incubated with 0 or 10 µg of nuclear extracts in the presence of the indicated molar excess of the unlabelled probe and electrophoretic mobility assays were carried out as described in the legend to Figure 3 . The sequences of the wt and mt NF-E2 oligonucleotides are as described in the Materials and methods section.
The AP-1 binding site in the PPRS is important for TS gene expression
Computer searches for the recognition sites of transcription factors in the PPRS, using the tfsites:dat program of the Wisconsin Package, identified only an AP-1-like element (k56 tgattca k50, ref. [25] ). To evaluate the importance of PPRS " , PPRS # , the AP-1 binding site, and the sequence near the transcription start site (k12 to k4 bp) on TS gene expression, these sequences, alone or in combination, were internally deleted from the phTS365\luc vector and the resulting plasmids used in transient assays. As shown in Figure 5 , deletion of the PPRS (construct 2) reduced the promoter activity by " 75 %, which was almost equal to the sum of the losses in promoter activity caused by the deletion of PPRS " (construct 3) and PPRS # (construct 4). Interestingly, deletion of the AP-1 binding site (construct 5) decreased the reporter activity to a similar extent as though the entire PPRS " was deleted, indicating that the AP-1-binding site is crucial for enhancing TS promoter activity. Deletion of the sequence between k12 and k4 bp (construct 6) abolished 90 % of the promoter activity, suggesting that this sequence, rather than the PPRS # , might be an integral portion of the basal promoter. The results prompted us to investigate the role of AP-1 in TS gene expression. However, three experiments failed to confirm its involvement, as will be discussed later.
NF-E2 modulating TS gene expression in HL-60 cells
The binding site for NF-E2, a transcription factor recognizing the locus control region of the globin genes, overlaps with that of AP-1 [26] . We had found that the PPRS " contained a sequence (k60 tgctgattcat k50) nearly identical to the consensus NF-E2 binding site (t\c)gctga(c\g)tca(t\c) [26] . To test if NF-E2 could be the factor interacting with the P1 probe, we carried out bandshift assays using a 20 bp oligonucleotide containing the NF-E2 recognition sequence as the competitor. We first demonstrated that the NF-E2 probe could interact with protein factors in HL-60 nuclear extracts, as shown in the left-hand panel of Figure 6 . The competition of P1\protein complex by the wild-type versus
Figure 7 NF-E2 expression in HL-60 and other cultured cell lines
(A) RT-PCR amplification of NF-E2 cDNA. Total RNA (5 µg) was reverse-transcribed from RNA of the indicated cell lines and used for PCR amplification in the presence of two specific primers encompassing either the coding sequence of human NF-E2 cDNA [23] or a 300 bp fragment of the human GAPDH cDNA [24] . In the negative (k) control, no first-strand cDNA was used in the PCR reaction. The sequences of the primers used and the conditions for PCR reactions have been described in detail in the Materials and methods section. After 30 cycles of amplification, 5 µl of the products were resolved in a 1n2 % agarose gel. (B) Northern blot detection of NF-E2 mRNA. Aliquots (15 µg) of total RNA from each of the indicated cell lines were electrophoresed in a 1 % agarose gel, blotted on to a nylon membrane, and probed with the NF-E2 cDNA obtained by RT-PCR.
Table 1 Transactivation of luc gene expression by co-transfection of NF-E2 cDNA with TS promoter/luc constructs in CHO cells
CHO cells were transfected with 15 µg each of the indicated promoter/luc fusion constructs in the presence of the same amount of pCMV-NF-E2(j) or pCMV-NF-E2(k). The (j) and (k) signs indicate that the cDNA was cloned in the correct and reverse orientation, respectively. In the phTS365∆(PPRS 1 )/luc construct, the PPRS 1 (k90 to k50) has been deleted from the 365 bp promoter. Neither the pSV 2 /luc nor the pBCKD:E2/luc vector contains the NF-E2 recognition site in its promoter. The relative luciferase activity (RLU) was normalized with β-gal activity. Transactivation was expressed as the ratio of the luc activity obtained in the presence of pCMV-NF-E2(j) over that in the presence of pCMV-NF-E2(k). The data are the meanspS.D. of two experiments. mutant NF-E2 oligonucleotide was then compared, as shown in the middle and right-hand panels, respectively, of Figure 6 . At 50imolar excess, the wild-type NF-E2 oligonucleotide competed as efficiently as the authentic unlabelled P1 probe (see Figure 3) , while the mutant NF-E2 probe, which differs from the wild-type probe only by a GA AG transition in the 20 bp sequence, failed to compete, indicating that the competition by the wildtype probe was specific. For NF-E2 to be responsible for the formation of the P1\protein complex ( Figure 4 ) and to play any significant role in TS gene expression, it should be present in the TS-expressing HL-60 cells. Although NF-E2 has been shown to be expressed in erythrocytes, megakaryocytes and mast cells [26] , its presence in HL-60 cells (a myeloid cell line) has not been reported. RT-PCR
Luciferase activity
Transactivation (fold) Construct Co-transfection … NF-E2(j) NF-E2(k) [NF-E2(j)/NF-E2(k)]
Figure 8 Expression of luc activity under the control of various lengths of human TS promoter in different cell types
Cells were cultured in their respective media as specified in the Materials and methods section. Transfection was carried out by electroporation (HL-60 and K562) or lipofectamine (PLC/PRF/5, CHO and GH 3 ). Luc activity was normalized for the amount of protein used and for transfection efficiencies in each cell type, as determined by direct X-gal staining of the transfected cells [19] . For each cell type, triplicate samples were transfected, two for luc assay and one for X-gal staining. The data represent the averages of two independent assays. amplification of NF-E2 cDNA from HL-60 RNA was therefore carried out, using two specific primers encompassing the coding sequence of human NF-E2 cDNA [23] . As controls, RNAs from the NF-E2-positive HEL and K562 cells and the NF-E2-negative PLC\PRF\5 cells [23] were used. As shown in Figure 7 (A), significant amounts of a cDNA having the size expected for the coding sequence of NF-E2 cDNA (1n3 kb) were amplified from RNA of HL-60 and the two erythroid cell lines, K562 and HEL. No product was detectable from the RNA of hepatoma cells, although similar amounts of the control GAPDH cDNA were amplified from RNA of all cell types. This result is consistent with that of Figure 4 , indicating no significant interaction of P1 probe with the PLC\PRF\5 nuclear extracts. Following subcloning, the authenticity of the amplified cDNA as human NF-E2 cDNA was confirmed by end sequencing (" 200 bp from both ends) and restriction mapping with four (ApaI, HindIII, KpnI, XbaI) enzymes. The expression of NF-E2 mRNA in HL-60 cells was later verified by Northern blot analysis as shown in Figure 7(B) .
To demonstrate that NF-E2 was able to enhance TS promoter activity, the effect of co-transfection of NF-E2 cDNA on the expression of luc gene controlled by TS or other promoters was investigated. CHO cells were chosen as host cells, since they have no endogenous NF-E2, and can be transfected with high efficiency (" 50 %). The NF-E2 cDNA was cloned in the correct (j) and reverse (k) orientations under the control of the CMV promoter in pCMV\NF-E2(j) and pCMV\NF-E2 (k), respectively. As shown in Table 1 , the luc reporter activity controlled by the 365 bp promoter was 9n1-fold higher in cells co-transfected with pCMV\NF-E2(j) vector than those co-transfected with the pCMV\NF-E2(k) vector. The transactivation was mediated by the PPRS "
, as deletion of the sequence (k90 to k50) from the phTS365\luc construct abolished the transactivation. As negative controls, no significant transactivation of the reporter activity by NF-E2 could be detected when the luc gene was controlled by the SV40 promoter\enhancer or the BCKD:E # promoter.
TS promoter activity in other cell types
To evaluate the importance of cis-regulatory sequences in conferring cell-specific TS expression, selective constructs containing TS promoters from 90 bp to 5n5 kb were transfected into four non-TS-expressing cell lines, including two human (K562 and PLC\PRF\5) and two rodent (CHO and GH $ ) cell lines. As shown in Figure 8 , expression of the reporter gene was detectable in all cell types tested, albeit at a much lower efficiency. As the length of the promoter increased, the promoter activity in non-TS-expressing cells became less significant.
Cell-specific methylation at TS promoter
An increasing number of reports indicate that methylation at the promoter region can influence gene expression [27] . We therefore analysed the profiles of methylation at the 5n5 kb TS promoter for three human cell lines, HL-60, K562 and PLC\PRF\5. Sequencing and genomic Southern blot analyses indicated that there are three potential sites of methylation (CCGG, referred as I, II and III) in the 5n5 kb promoter, as depicted in Figure 9 (A). Genomic DNA from each cell line was first digested with HindIII or NcoI. The digested products were split into two aliquots, one further digested with HpaII, which does not digest methylated CCGG (CC m GG), and the other with MspI, which is insensitive to methylation of CCGG. The products were subjected to Southern blot analysis using a PstI probe. As shown in Figure  9 (A), each of the three cell lines exhibited a distinctive pattern of methylation at these three sites, which were independent of the restriction enzyme (HindIII or NcoI) chosen for initial genomic DNA digestion. A summary of the profiles of methylation derived from the Southern blot analyses was depicted in Figure  9 (B). No methylation within the 5n5 kb promoter could be detected in the hepatoma cells, as an identical pattern was observed with either HpaII or MspI digestion. Neither site II or site III was methylated in K562 cells, while a partial methylation at site I was observed, as evidenced by the presence of a 2n0 kb fragment. In contrast, complete methylation at site I (lack of the 1n57 kb fragment) and partial methylation at the other two sites were seen in HL-60 cells.
Partial methylation at TS promoter is cell cycle-independent
Since partial methylation was observed in two of the cell lines used, we wondered whether methylation at the promoter was cell-cycle dependent. In order to address this question, DNA from HL-60 cells synchronized by either serum starvation or phorbol 12-myristate 13-acetate (PMA)-induced differentiation was analysed. In serum starvation, which arrests the cells at G ! phase [28] , HL-60 cells were cultured in a serum-free medium for 60 h. For PMA-induced differentiation, HL-60 cells (8i10& cells\ml) were treated with PMA (Gibco BRL) at a final concentration of 33 nM for 36 h, which arrests the cells in G " phase [29] . Within 4 h of PMA treatment, more than 95 % of the cells became attached to the plates. As shown in Figure 9 (C), the profiles of DNA methylation at the promoter were not affected by either method of synchronization, suggesting that partial methylation is probably not due to mixed populations of cells at different stages of the cell cycle.
DISCUSSION
Our promoter analysis revealed that TS gene expression is regulated by positive as well as negative cis-elements. The maximal promoter activity was localized within 285 bp, 75 % of which could be accounted for by the 66 bp PPRS. The PPRS is enhancer-like, since its activity depends strictly on its position but much less on its orientation. One likely interpretation is that close proximity of the PPRS-binding proteins to those in the basal transcriptional machinery was required to achieve optimal interactions. The sequence upstream of k285 bp consists mostly of repressive elements. The major repressive sequence (k365 to k665) functions independent of orientation and position, and therefore conforms to the definition of a silencer. The silencer activity did not require the presence of the PPRS " and showed no cell specificity as it worked on the SV40 promoter\enhancer and in several cell types (Figure 8 ). Attempts to localize the core silencer sequence by 5h deletion from k665 bp resulted in gradient increases in the promoter strength, while gel-shift assays using the 300-bp silencer probe and HL-60 nuclear extracts failed to detect significant association of protein factors (results not shown). We suspect that the silencer is composed of multiple elements which either alter chromatin structure or bind to repressor proteins low in affinity and\or abundance. It has been demonstrated that some DNA sequences, which failed to bind protein factors, could alter chromatin structure and affect the efficacy of transcription [30] . Whether this silencer sequence works in a similar fashion remains to be determined. The sequence between k755 bp and k5n5 kb caused an additional " 30 % reduction in reporter activity in HL-60 cells. The gradual decline of the promoter strength indicates that transcriptional control of the TS gene may rely on the coordinate activity of multiple but individually weak cis-and trans-acting factors. It has been shown that such multiple weak effectors can form an array capable of directing transcription with a high degree of specificity [31] .
We have demonstrated that at least two protein factors in HL-60 cell nuclear extracts specifically interact with the PPRS. The one interacting with P1 at the NF-E2\AP-1-binding site is cellspecific, while that interacting with the P2 is probably ubiquitous. Three lines of evidence (results not shown) suggest that AP-1 is not involved in the PPRS " -mediated transactivation. First, oligonucleotides containing either the consensus (tgactca) or the mutated (tgacttg) AP-1-binding site competed 20-fold less efficiently than the unlabelled authentic P1 probe. Secondly, antibodies against either c-Jun or c-Fos (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) could not supershift the complex or inhibit its formation in band-shift assays. Thirdly, PMA, known to stimulate AP-1 activity in HL-60 cells [25] , induced a 20-fold increase of luc expression in the SV40\luc-transfected HL-60 cells, but failed to stimulate luc activity in cells transfected with several TS promoter\luc constructs bearing the PPRS " . Our results strongly suggest that NF-E2 is responsible for the PPRS " -dependent transactivation of luc activity. The 20 bp NF-E2 oligonucleotide used in the competition assays ( Figure 6 ) shares only a 10 bp (the nearly consensus NF-E2-binding site) homology with the P1 sequence, yet competed efficiently for the entire complex formed between the authentic P1 sequence and HL-60 nuclear extracts ( Figure 6 ). Furthermore, the transactivation by NF-E2 in CHO cells relied strictly on the presence of PPRS " in the vectors (Table 1) . We have also found significant, though less (1n5-to 2-fold), transactivation of luc reporter expression by NF-E2 in HL-60 and another NF-E2-positive K562 cell line (results not shown). The reduction in transactivation is presumably due partly to the fact that NF-E2 protein is already abundant in these cell lines ( Figure 7 ) and partly to the relatively lower efficiency of transfection (3-5 %) achievable in these two haematopoietic cell lines. NF-E2 has been shown to function as an obligate heterodimer with p18, a ubiquitous protein which increases the binding specificity for the bases lying outside the AP-1 core of the 11 bp NF-E2 consensus sequence [26] . Since NF-E2 alone cannot directly bind DNA [23, 32] , it is likely that transactivation of the TS promoter is also mediated by the NF-E2\p18 complex.
In addition to the PPRS, several upstream repressive sequences have been localized within the 5n5 kb TS promoter. Since TS directly controls the production of the potent autacoid TxA # , it is likely that, in addition to ' suicide inactivation ' [12, 13] and alternative splicing of the TS transcript [14] , transcriptional repression of the TS gene may provide an additional mechanism to curtail the level of TS. Although these repressors were not sufficient to confer cell-type specificity (Figure 8) , the difference in the promoter activity between TS-expressing and non-TSexpressing cells became more significant as the length of the promoter was increased, suggesting that differences in the level of repressor proteins among cell lines may contribute, at least in part, to cell-specific expression of the TS gene.
We have demonstrated cell-specific patterns of methylation at the 5n5 kb TS promoter in human cell lines. The TS promoter was more extensively methylated at all three sites in HL-60 cells, as compared with that of the two non-TS-expressing cell lines. The methylation did not change in response to growth arrest by serum starvation or induced differentiation, suggesting that it is probably intrinsic and independent of cell cycles. Cell-specific partial methylation at promoters has also been reported for several other genes [33] [34] [35] . Hypermethylation, though generally associated with silent genes, has been shown to enhance gene expression. Both insulin-like growth factor II (igf2) and its receptor (igf2R) genes are expressed from the more methylated alleles [36, 37] . It has been shown that the sensitivity of a eukaryotic promoter to methylation depends primarily on the position and less on the absolute number of these methylation sites [38] . DNA methylation has been demonstrated to interfere, from a distance, with the activity of the thyroglobulin gene promoter [39] . In this regard, it is worth noting that all three sites of methylation in the 5n5 kb TS promoter are located in regions which exhibit a repressive effect on the reporter gene expression. We have recently found that the methylation pattern at the TS gene promoter of another TS-expressing cell line, HEL, is identical to that of HL-60 cells (results not shown). Further studies are required in order to elucidate whether TS gene expression is actually under epigenetic regulation by methylation and the mechanisms involved.
